What stocks does SBI HEALTHCARE OPPORTUNITIES FUND hold?

SBI HEALTHCARE OPPORTUNITIES FUND holds a portfolio of Indian equity stocks disclosed monthly by SBI Mutual Fund to AMFI. The complete current holdings with weights and month-over-month changes are available on this page. Data is sourced from official AMFI portfolio disclosures.

Which AMC manages SBI HEALTHCARE OPPORTUNITIES FUND?

SBI HEALTHCARE OPPORTUNITIES FUND is managed by SBI Mutual Fund, a SEBI-registered Asset Management Company in India.

What category is SBI HEALTHCARE OPPORTUNITIES FUND?

SBI HEALTHCARE OPPORTUNITIES FUND is classified as a Equity mutual fund under SEBI's mutual fund categorisation framework.

How often is SBI HEALTHCARE OPPORTUNITIES FUND portfolio data updated?

Portfolio holdings for SBI HEALTHCARE OPPORTUNITIES FUND are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

← SBI Mutual Fund

SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

Equity Data as of May 2026 Comparing Apr 2026 → May 2026

Share: WhatsApp X

Stocks Held

May 2026

Equity Holdings

₹4,353.59 Cr

Equity only, excl. debt & cash

Top 5 Weight

33.9%

Moderate

Top 10 Weight

52.2%

Moderate

Changes

3 new · 2 exits

Top Sector

Pharmaceuticals & Biotechnology

64.9% of portfolio

📋 What Happened This Month SBI HEALTHCARE OPPORTUNITIES FUND made 3 new additions and exited 2 stocks this month. The biggest new buy was Cipla Limited (Pharmaceuticals & Biotechnology) at 1.84% weight. SANOFI CONSUMER HEALTHCARE was the biggest exit (Pharmaceuticals & Biotechnology), which was held at 0.44%. Among existing holdings, Acutaas Chemicals Ltd saw the biggest increase — now at 6.17% of the portfolio. Lupin Limited was trimmed the most, now at 1.99%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 64.9%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

How Has the NAV Performed?

1 year history · SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

+4.28%

+15.37%

+15.55%

+16.00%

Latest NAV

₹560.52

24 Jun 2026

52W High

₹560.52

At High

52W Low

₹436.68

+28% from Low

Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025

-2.5%

2024

+43.8%

2023

+39.7%

2022

-5.0%

2021

+21.5%

2020

+67.7%

2019

+0.5%

2018

-8.8%

2017

+3.3%

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

16.8%

+ve in 66% windows

86.5% / -18.1%

3Y Rolling Avg

17.7% p.a.

+ve in 85% windows

32.2% / -9.6%

5Y Rolling Avg

18.8% p.a.

+ve in 100% windows

34.0% / 6.9%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

-13.5%

Rec: Jul 2025 (7 mo)

COVID-19 Crash

-22.7%

Rec: Apr 2020 (1 mo)

2022 Rate Hike

-16.0%

Rec: May 2023 (1yr 4mo)

2018 IL&FS

-14.4%

Rec: Apr 2020 (2yr 1mo)

Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. What do these mean? →

Sharpe Ratio (3Y)

1.59

Return per unit of risk. >1 is good.

Sortino Ratio (3Y)

2.32

Penalises downside volatility only.

Std Deviation (3Y)

12.8%

Lower = more consistent returns.

NAV Chart ₹560.52 24 Jun 2026

Simple Moving Avg: Click to draw · click again to remove

SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

Chart shows indexed performance (base = 100). Actual NAV: ₹560.52

Sector Shift Industry allocation month-over-month

Mar 2026 → Apr 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	64.8%	64.4%	▼ -0.5%
Healthcare Services	24.5%	24.4%	● -0.1%
Chemicals & Petrochemicals	3.6%	3.4%	▼ -0.2%
Healthcare Equipment & Supplies	1.9%	2.2%	▲ +0.4%
Retailing	0.4%	0.3%	▼ -0.1%

Apr 2026 → May 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	64.4%	64.9%	▲ +0.6%
Healthcare Services	24.4%	25.9%	▲ +1.5%
Chemicals & Petrochemicals	3.4%	2.7%	▼ -0.7%
Healthcare Equipment & Supplies	2.2%	1.9%	▼ -0.4%
Retailing	0.3%	0.0%	▼ -0.3%

🟢

Biggest New Buy

Cipla Limited

1.84% weight · Pharmaceuticals & Biotechnology

🔴

Biggest Exit

SANOFI CONSUMER HEALTHCARE

0.44% was held · Pharmaceuticals & Biotechnology

↑

Biggest Add

Acutaas Chemicals Ltd

+0.77% · now 6.17%

↓

Biggest Trim

Lupin Limited

-1.85% · now 1.99%

🤝 Other funds also bought this month

Cipla Limited 27 funds

Dr. Lal Path Labs Limited 18 funds

Global Health Limited 12 funds

👋 Other funds also exited

MedPlus Health Services Limited 4 funds

What Changed in the Portfolio This Month?

Comparing Apr 2026 → May 2026

Apr 2026 → May 2026

🟢 3 New Entries 🔴 2 Exits ↑ 11 Increased ↓ 16 Decreased

#	Stock	Sector	Weight (May 2026)
1	Cipla Limited ₹84.06 Cr	Pharmaceuticals & Biotechnology	1.84%
2	Global Health Limited ₹66.58 Cr	Healthcare Services	1.46%
3	Dr. Lal Path Labs Limited ₹38.58 Cr	Healthcare Services	0.84%

#	Stock	Sector	Last Weight (Apr 2026)
1	SANOFI CONSUMER HEALTHCARE ₹19.06 Cr	Pharmaceuticals & Biotechnology	0.44%
2	MedPlus Health Services Limited ₹13.08 Cr	Retailing	0.30%

#	Stock	Sector	Apr 2026	May 2026	Change
1	Acutaas Chemicals Ltd ₹281.93 Cr	Pharmaceuticals & Biotechnology	5.40%	6.17%	+0.77%
2	Aurobindo Pharma Limited ₹178.30 Cr	Pharmaceuticals & Biotechnology	3.21%	3.90%	+0.69%
3	Cohance Lifesciences Limited ₹77.67 Cr	Pharmaceuticals & Biotechnology	1.12%	1.70%	+0.58%
4	Gland Pharma Limited ₹135.00 Cr	Pharmaceuticals & Biotechnology	2.43%	2.96%	+0.53%
5	Laurus Labs Limited ₹163.44 Cr	Pharmaceuticals & Biotechnology	3.06%	3.58%	+0.52%
6	Biocon Limited ₹160.74 Cr	Pharmaceuticals & Biotechnology	3.12%	3.52%	+0.40%
7	Apollo Hospitals Enterprise Limited ₹245.30 Cr	Healthcare Services	5.30%	5.37%	+0.07%
8	Jupiter Life Line Hospitals Ltd ₹119.44 Cr	Healthcare Services	2.55%	2.62%	+0.07%
9	Sai Life Sciences Limited ₹116.00 Cr	Pharmaceuticals & Biotechnology	2.47%	2.54%	+0.07%
10	Nephrocare Health Services Ltd ₹47.90 Cr	Healthcare Services	0.98%	1.05%	+0.07%
11	Rainbow Childrens Medicare Limited ₹41.41 Cr	Healthcare Services	0.87%	0.91%	+0.04%

#	Stock	Sector	Apr 2026	May 2026	Change
1	Lupin Limited ₹90.71 Cr	Pharmaceuticals & Biotechnology	3.84%	1.99%	-1.85%
2	Aether Industries Limited ₹120.78 Cr	Chemicals & Petrochemicals	3.35%	2.65%	-0.70%
3	Sun Pharmaceutical Industries Limited ₹503.78 Cr	Pharmaceuticals & Biotechnology	11.71%	11.03%	-0.68%
4	Krishna Institute Of Medical Sciences Limited ₹91.06 Cr	Healthcare Services	2.47%	1.99%	-0.48%
5	Anthem Biosciences Limited ₹136.96 Cr	Pharmaceuticals & Biotechnology	3.45%	3.00%	-0.45%
6	Mankind Pharma Limited ₹133.03 Cr	Pharmaceuticals & Biotechnology	3.33%	2.91%	-0.42%
7	Max Healthcare Institute Limited ₹217.15 Cr	Healthcare Services	5.17%	4.76%	-0.41%
8	Alkem Laboratories Limited ₹96.22 Cr	Pharmaceuticals & Biotechnology	2.50%	2.11%	-0.39%
9	Poly Medicure Limited ₹86.38 Cr	Healthcare Equipment & Supplies	2.24%	1.89%	-0.35%
10	Concord Biotech Limited ₹75.69 Cr	Pharmaceuticals & Biotechnology	1.90%	1.66%	-0.24%
11	Divi's Laboratories Limited ₹300.02 Cr	Pharmaceuticals & Biotechnology	6.77%	6.57%	-0.20%
12	Fortis Healthcare Limited ₹139.27 Cr	Healthcare Services	3.20%	3.05%	-0.15%
13	Gufic Biosciences Ltd. ₹16.69 Cr	Pharmaceuticals & Biotechnology	0.46%	0.37%	-0.09%
14	Aster DM Healthcare Limited ₹174.80 Cr	Healthcare Services	3.89%	3.83%	-0.06%
15	Ajanta Pharma Limited ₹87.87 Cr	Pharmaceuticals & Biotechnology	1.96%	1.92%	-0.04%
16	Sudeep Pharma Limited ₹100.93 Cr	Pharmaceuticals & Biotechnology	2.23%	2.21%	-0.02%

What Stocks Does This Fund Hold?

32 stocks — May 2026

#	Stock	Sector	Weight & Value
1	Sun Pharmaceutical Industries Limited ₹503.78 Cr	Pharmaceuticals & Biotechnology	11.03%
2	Divi's Laboratories Limited ₹300.02 Cr	Pharmaceuticals & Biotechnology	6.57%
3	Acutaas Chemicals Ltd ₹281.93 Cr	Pharmaceuticals & Biotechnology	6.17%
4	Apollo Hospitals Enterprise Limited ₹245.30 Cr	Healthcare Services	5.37%
5	Max Healthcare Institute Limited ₹217.15 Cr	Healthcare Services	4.76%
6	Aurobindo Pharma Limited ₹178.30 Cr	Pharmaceuticals & Biotechnology	3.90%
7	Aster DM Healthcare Limited ₹174.80 Cr	Healthcare Services	3.83%
8	Laurus Labs Limited ₹163.44 Cr	Pharmaceuticals & Biotechnology	3.58%
9	Biocon Limited ₹160.74 Cr	Pharmaceuticals & Biotechnology	3.52%
10	Torrent Pharmaceuticals Limited ₹158.79 Cr	Pharmaceuticals & Biotechnology	3.48%
11	Fortis Healthcare Limited ₹139.27 Cr	Healthcare Services	3.05%
12	Anthem Biosciences Limited ₹136.96 Cr	Pharmaceuticals & Biotechnology	3.00%
13	Gland Pharma Limited ₹135.00 Cr	Pharmaceuticals & Biotechnology	2.96%
14	Mankind Pharma Limited ₹133.03 Cr	Pharmaceuticals & Biotechnology	2.91%
15	Aether Industries Limited ₹120.78 Cr	Chemicals & Petrochemicals	2.65%
16	Jupiter Life Line Hospitals Ltd ₹119.44 Cr	Healthcare Services	2.62%
17	Sai Life Sciences Limited ₹116.00 Cr	Pharmaceuticals & Biotechnology	2.54%
18	Sudeep Pharma Limited ₹100.93 Cr	Pharmaceuticals & Biotechnology	2.21%
19	Alkem Laboratories Limited ₹96.22 Cr	Pharmaceuticals & Biotechnology	2.11%
20	Krishna Institute Of Medical Sciences Limited ₹91.06 Cr	Healthcare Services	1.99%
21	Lupin Limited ₹90.71 Cr	Pharmaceuticals & Biotechnology	1.99%
22	Ajanta Pharma Limited ₹87.87 Cr	Pharmaceuticals & Biotechnology	1.92%
23	Poly Medicure Limited ₹86.38 Cr	Healthcare Equipment & Supplies	1.89%
24	Cipla Limited ₹84.06 Cr	Pharmaceuticals & Biotechnology	1.84%
25	Cohance Lifesciences Limited ₹77.67 Cr	Pharmaceuticals & Biotechnology	1.70%
26	Concord Biotech Limited ₹75.69 Cr	Pharmaceuticals & Biotechnology	1.66%
27	Abbott India Limited ₹67.14 Cr	Pharmaceuticals & Biotechnology	1.47%
28	Global Health Limited ₹66.58 Cr	Healthcare Services	1.46%
29	Nephrocare Health Services Ltd ₹47.90 Cr	Healthcare Services	1.05%
30	Rainbow Childrens Medicare Limited ₹41.41 Cr	Healthcare Services	0.91%
31	Dr. Lal Path Labs Limited ₹38.58 Cr	Healthcare Services	0.84%
32	Gufic Biosciences Ltd. ₹16.69 Cr	Pharmaceuticals & Biotechnology	0.37%